Related Interviews

Oncology and Orphan Drugs Retain Pricing Power
August 14, 2013

U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012

Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010

INVESTING IN GROWTH STOCKS - WILLIAM F. DWYER - MTB INVESTMENT ADVISORS, INC.
August 11, 2008

ORTHOPEDICS: SPINE & BIOLOGICS - WILLIAM J. PLOVANIC - CANACCORD ADAMS INC.
June 30, 2008

LARGE CAP GARP INVESTING - SCOTT SINDELAR & PETER GOLDMAN - CHICAGO ASSET MANAGEMENT COMPANY
December 24, 2007

MANUFACTURED HOUSING - KATHRYN I. THOMPSON - AVONDALE PARTNERS, LLC
April 30, 2007

DIGITAL MARKETING TECHNOLOGY PROVIDERS - KYLE EVANS - STEPHENS INC.
November 06, 2006

ROUNDTABLE FORUM: BROADCASTING
November 06, 2006

Joseph Cummins - Amarillo Biosciences Inc (amar)
July 03, 2006

L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005

MID-TIER GOLD PRODUCERS: PAUL O'BRIEN - RAYMOND JAMES LTD
June 27, 2005

ROUNDTABLE FORUM: BIOTECHNOLOGY
June 27, 2005

William Koster - Neurogen Corporation (nrgn)
October 17, 2003

Office & Industrial Reits: David Fick - Legg Mason Wood Walker
August 18, 2003

Keith Bigsby - Tadpole Technology Plc (tad.l)
June 30, 2003

Thomas Okarma - Geron Corporation (gern)
June 02, 2003

Mark Davidson - Fiduciary Services Corporation
July 08, 2002

David U'prichard - 3-dimensional Pharmaceuticals Inc (dddp)
October 12, 2001

Dr. Christopher Wood - Bioenvision (biov)
June 07, 2001

Investing In Biotechnology: Panel, Prudential Vector Healthcare Group
December 18, 2000

Kevin C. Johnson - Dianon Systems Inc (dian)
January 13, 2000